Features

Sort by: Newest first Oldest first A-Z Z-A

Have legislative changes curbed use of ‘legal highs’? Subscription

While the Psychoactive Substances Act 2016 appears to have controlled circulation of novel psychoactive substances, formerly known as ‘legal highs’, on the high street, a Home Office review has proved what many experts predicted — that the legislation would drive sales onto the streets and the dark web.
Why are pharmacy schools struggling to fill places? Subscription

A decline in the number of applications to pharmacy schools and more students being accepted through clearing has led to concerns over the future pharmacy workforce.
Repurposing Viagra: the ‘little blue pill’ for all ills? Subscription

Study results suggest that PDE-5 inhibitors could have a role in treating cancer, heart failure, neurodegenerative diseases, circulatory disorders and even infectious diseases, but the road to approval for new indications may not be smooth.
Deprescribing: the fightback against polypharmacy has begun Subscription

Polypharmacy among older people is at an all-time high, prompting a necessary focus on withdrawing inappropriate medicines. However, evidence-based guidelines are needed to overcome barriers to deprescribing.
Why are few pharmacies using the summary care record? Subscription

Lack of time and not being able to access the required information means that many community pharmacists in England are not using abbreviated patient records online.
Tipping the scales: the problem of drug dosing in obese patients Subscription

As obesity levels rise, pharmacists are finding they need new tools to ensure they adequately tailor the amount of medicine patients receive.
'Like a hug from everyone who loves you' — how MDMA could help patients with trauma Subscription

When combined with intensive psychotherapy sessions, MDMA — commonly known as ecstasy — has elicited impressive results in phase II trials and a global phase III study is just beginning.
Ten things pharmacists should know about biologics and biosimilars Subscription

As healthcare professionals prepare for blockbuster biologic Humira to come off patent on 16 October 2018, we highlight what pharmacists need to know about switching from originator biologics to biosimilars in order to get the best value from these medicines.
Why the 2018 flu season could be a major challenge for pharmacy Subscription

Despite the success pharmacy had in 2017 with offering influenza vaccination to people across the UK, winter 2018 is shaping up to be a difficult season, with different vaccines for different groups, staggered deliveries until December and guidance that makes patient prioritisation a problem.
Body bionics: how the next generation of biosensors could revolutionise drug delivery Subscription

Smaller, smarter and more sensitive — how four new technologies could change the way drugs are monitored and administered.